D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia

Clinical trial NCT00237809 · COMPLETED

Trial details

NCT number: NCT00237809
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2002-09-01
Primary completion: 2010-12-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.